You just read:

MabVax Therapeutics Commences Patient Dosing in MVT-1075 Radioimmunotherapy Phase 1 Clinical Trial for the Treatment of Pancreatic, Colon and Lung Cancers

News provided by

MabVax Therapeutics Holdings, Inc.

Jun 27, 2017, 08:05 ET